JA GHI — EU Global Health Strategy Dashboard
Overview — Sweden
On this page you can find all the survey results for this country. Click on the filters button to see the data analysis for the specific topic, or on the All topics button to view all the charts.
View:
Respondents
0
Know the EU strategy
very well (27.3%)
0%
Support alignment national – EU strategy
0%
Aware of national GH strategy
0%
Favour wider dissemination
0%
Responding stakeholders
Government and Public Authorities 1, Academia and Public Research Institutions 5, Healthcare Providers 0, Civil Society 4, Private Sector 1.
Awareness of the EU Global Health Strategy
Is your institution aware of the existence of the EU Global Health Strategy and of its content?
Yes, very well 27.3%, Yes, to some extent 54.6%, No 18.1%.
Yes, well aware 27.3% Yes, to some extent 54.6% No 18.1%
How respondents became aware of the EU strategy
How did your institution become aware of it?
EU institutional channels 33.3%, Conferences 33.3%, Several channels 22.2%, Other 11.1%.
National global health strategy in Sweden
Are you aware of whether your country has a National Strategy for Global Health?
Yes (a standalone one) 45.5%, Yes (embedded) 9.1%, Don't know 45.5%.
Yes (a standalone one) 45.5% Yes, but embedded in another strategy/policy 9.1% Don't know 45.5%
Awareness of Sweden's Global Health Ambassador
Are you aware if your country has a Global Health Ambassador?
Yes 100%.
Yes 100%
Target audiences for EU strategy communication
To which stakeholders should the communication on the EU Global Health Strategy be addressed?
Academy and corporate sector 55.6%, Civil society 33.3%, Other 11.1%.
Recommended communication channels
Which communication channels should be used to further disseminate information about the EU Global Health Strategy and its contents?
E-mails 44.4%, Social media 22.2%, Other 22.2%, Meetings 11.1%.
Coordination among key actors
Is there a formal or informal coordination mechanism among the actors holding major responsibilities for launching, financing, implementing Global Health initiatives/projects?
Yes, formal 36.4%, Yes, informal 9.1%, Don't know 54.6%.
Yes, formal 36.4% Yes, informal 9.1% Don't know 54.6%

Key messages

This is a summary of the key messages emerging from the open-ended responses of the Swedish stakeholders surveyed, organized by theme.

01

Need for alignment

Universal support, nuanced expectations
  • All 11 respondents (100%) consider alignment between national and EU GH Strategies important — reflecting a strong institutional consensus in Sweden.
  • Respondents see alignment as essential for enabling synergies, avoiding fragmentation, ensuring implementation, and strengthening the EU's global health influence. Some stress that alignment should be mutual, noting the EU Strategy was not developed through broad consultation.
  • Shared health outcome goals would enable better impact assessment and comparability across countries, with patients at the centre of evaluation — a key priority for Swedish respondents.
02

Communication and implementation

Academia first, outcomes-driven
  • 81.8% support wider dissemination of the EU GH Strategy. The primary target audience is the academy and corporate sector (55.6%), followed by civil society (33.3%).
  • E-mails (44.4%) are the leading recommended channel, alongside social media (22.2%) and institutional meetings (11.1%). Qualitative feedback also mentions seminars, newsletters, press, and academic platforms.
  • Respondents call for implementation to be measured by real-world health outcomes — not internal outputs — and propose national networks of appointed focal points, an annual European Global Health Assembly, and more flexible engagement at the agency level.
03

National strategy

A strategy that many don't know about
  • Sweden is one of only five EU countries with a national GH strategy. Yet only 54.6% of respondents are aware of it (45.5% as a standalone strategy, 9.1% as embedded) — revealing a significant domestic awareness gap.
  • Among the 5 respondents who were unaware, 80% nonetheless considered having a national GH strategy important — underlining its perceived value even among those who do not know it exists.
  • Sweden's rich GH policy landscape includes bilateral development cooperation agreements, the Swedish WHO strategy (2021), the SRHR strategy in Africa (2022–36), and the antibiotic resistance strategy (2024–25) — all contributing to global health without constituting a single, unified GH strategy.
04

National coordination and key actors

Strong anchors, limited visibility
  • Only 45.5% of respondents report coordination mechanisms (36.4% formal, 9.1% informal); 54.6% don't know — suggesting limited visibility of existing structures despite a well-developed GH institutional landscape.
  • Key GH actors include Folkhälsomyndigheten, the Ministry of Health, Sida, Folke Bernadotteakademin, and Karolinska Institutet — a broad mix of government, academic, and development cooperation bodies.
  • Sweden has a confirmed Global Health Ambassador (100%), providing a strong institutional anchor for EU-level GH engagement — an asset that could be leveraged to improve coordination visibility across sectors.